A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : DEN / dengue

[Related PubMed/MEDLINE]
Total Number of Papers: 186
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   DEN  (>> Co-occurring Abbreviation)
Long Form:   dengue
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Genetic characterization of dengue virus serotype 2 isolated from dengue fever outbreaks in eastern Uttar Pradesh and western Bihar, India. DV
2020 High diversity of mosquito vectors in Cambodian primary schools and consequences for arbovirus transmission. JE
2020 In vitro shared transcriptomic responses of Aedes aegypti to arboviral infections: example of dengue and Rift Valley fever viruses. CLIP, RVF
2020 Inapparent dengue virus infection among students in Mandalay, Myanmar. DENV
2020 Spatiotemporal Distribution of Dengue and Chikungunya in the Hindu Kush Himalayan Region: A Systematic Review. CHIK, HKH, PRISMA
2020 Vaccines Against Dengue and West Nile Viruses in India: The Need of the Hour. JE, NAb, NPs, WN
2019 Low to medium-low risk perception for dengue, chikungunya and Zika outbreaks by infectious diseases physicians in France, Western Europe. CHIK, ID
2019 Molecular studies on dengue viruses detected in patients from Central India. DENVs
2018 Experimental Zika virus infection in Aedes aegypti: Susceptibility, transmission & co-infection with dengue & chikungunya viruses. CHIK, CHIKV, PID, ZIKV
10  2018 Patterns of occurrence of dengue and chikungunya, and spatial distribution of mosquito vector Aedes albopictus in Swabi district, Pakistan. CHK
11  2018 The occurrence, diversity and blood feeding patterns of potential vectors of dengue and yellow fever in Kacheliba, West Pokot County, Kenya. YF
12  2017 Assessment of risk of dengue and yellow fever virus transmission in three major Kenyan cities based on Stegomyia indices. BI, CI, HI, YF
13  2017 Associations of tumor necrosis factor-alpha-308 polymorphism with dengue infection: A systematic review and meta-analysis. DF, DHF, HWC, OR, SCA, TNFalpha -308
14  2017 Chikungunya Detection during Dengue Outbreak in Sumatra, Indonesia: Clinical Manifestations and Virological Profile. CHIK, CHIKV
15  2017 Clinical and laboratory profile of dengue viral infections in and around Mangalore, India. DENV, NS1, RT-PCR
16  2017 Utility of dengue NS1 antigen rapid diagnostic test for use in difficult to reach areas and its comparison with dengue NS1 ELISA and qRT-PCR. DENV, ELISA, NS1, RDT
17  2016 A survey of malaria and some arboviral infections among suspected febrile patients visiting a health centre in Simawa, Ogun State, Nigeria. CHK, GLURP, PCR, RDT
18  2016 Chikungunya and dengue virus infections during pregnancy: seroprevalence, seroincidence and maternal-fetal transmission, southern Thailand, 2009-2010. CHIK, CHIKV, DENV
19  2016 Zika virus: Indian perspectives. CHIK, ZiV
20  2015 A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease. ---
21  2015 A Re-Examination of the History of Etiologic Confusion between Dengue and Chikungunya. CHIK
22  2015 Association of combinations of interleukin-10 and pro-inflammatory cytokine gene polymorphisms with dengue hemorrhagic fever. DF, DHF, HC, SNPs
23  2015 Emergence of dengue in tribal villages of Mandla district, Madhya Pradesh, India. DENV, nRT-PCR
24  2015 Molecular Epidemiology of Dengue Viruses Co-circulating in Upper Myanmar in 2006. DEN-4, DENV, DENV-3
25  2015 Polymorphisms in the retinoic acid-1 like-receptor family of genes and their association with clinical outcome of dengue virus infection. DF, DHF, HCs, MDA
26  2015 Profiling of viral proteins expressed from the genomic RNA of Japanese encephalitis virus using a panel of 15 region-specific polyclonal rabbit antisera: implications for viral gene expression. JEV, WN, YF
27  2015 Trends in Dengue Cases Imported into the United States from Pan America 2001-2012. ---
28  2014 First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies. ADE, DENV
29  2014 High level of vector competence of Aedes aegypti and Aedes albopictus from ten American countries as a crucial factor in the spread of Chikungunya virus. CHIK, CHIKV, CHIKV, ECSA, TE
30  2014 Investigating the efficacy of monovalent and tetravalent dengue vaccine formulations against DENV-4 challenge in AG129 mice. TDV, TDV-2
31  2013 Association of promoter region polymorphisms of CD209 gene with clinical outcomes of dengue virus infection in Western India. OR
32  2013 Emerging and re-emerging arboviral diseases in Southeast Asia. CHIK, JE, KFDV, WNV
33  2013 High efficiency of temperate Aedes albopictus to transmit chikungunya and dengue viruses in the Southeast of France. AL-CSM, CHIK, p.i
34  2013 Hypertonic saline reduces vascular leakage in a mouse model of severe dengue. DHF/DSS, HTS
35  2013 M cell-targeting ligand and consensus dengue virus envelope protein domain III fusion protein production in transgenic rice calli. cEDIII
36  2013 Polymorphisms in the oligoadenylate synthetase gene cluster and its association with clinical outcomes of dengue virus infection. HCs, OAS, OR, Pc, SNPs
37  2013 Profile of human leukocyte antigen class I alleles in patients with dengue infection from Western India. DF, DHF, HCs, HLA, OR
38  2012 Flaviviruses and their antigenic structure. JE, TBE, WN, YF
39  2012 Genetic structure and phylogeography of Aedes aegypti, the dengue and yellow-fever mosquito vector in Bolivia. YF
40  2012 Identification of dengue virus in Aedes mosquitoes and patients' sera from Si Sa Ket Province, Thailand. DF, DHF, DSS
41  2012 Prevalence and molecular characterization of dengue viruses serotypes in 2010 epidemic. DF, PCR
42  2012 The native Wolbachia symbionts limit transmission of dengue virus in Aedes albopictus. CHIK, CHIKV, DENV
43  2012 Using recombinant DNA technology for the development of live-attenuated dengue vaccines. DENV, DF, DHF, DSS
44  2011 A single amino acid in nonstructural protein NS4B confers virulence to dengue virus in AG129 mice through enhancement of viral RNA synthesis. DENV-2
45  2011 Subcutaneous infection with non-mouse adapted Dengue virus D2Y98P strain induces systemic vascular leakage in AG129 mice. DHF/DSS, i.p, s.c
46  2010 A non mouse-adapted dengue virus strain as a new model of severe dengue infection in AG129 mice. ---
47  2010 Orally co-Infected Aedes albopictus from La Reunion Island, Indian Ocean, can deliver both dengue and chikungunya infectious viral particles in their saliva. CHIK
48  2010 Serological investigations of flavivirus prevalence in Khammouane Province, Lao People's Democratic Republic, 2007-2008. JE
49  2009 Analysis of flavivirus NS5 methyltransferase cap binding. MTase, YF
50  2009 Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III. mAbs
51  2009 Induction of neutralization antibodies in mice by Dengue-2 envelope DNA vaccines. ID, IM, tPA
52  2009 Monoclonal antibody to dengue capsid protein: its application in dengue studies. DF, DHF/DSS, mAbs
53  2009 Multiple recombinants in two dengue virus, serotype-2 isolates from patients from Oaxaca, Mexico. DENV
54  2009 Pathogenesis and prevention of dengue virus infection: state-of-the-art. ---
55  2008 An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes. EDIII
56  2008 Development and evaluation of a 1-step duplex reverse transcription polymerase chain reaction for differential diagnosis of chikungunya and dengue infection. CHIK, CHIKV, D-RT-PCR, DENV
57  2008 Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses. DENV, PDVI, PRNT, WHO
58  2008 Introduction of Aedes albopictus in Gabon: what consequences for dengue and chikungunya transmission? CHIKV, DENV
59  2008 Specific genetic markers for detecting subtypes of dengue virus serotype-2 in isolates from the states of Oaxaca and Veracruz, Mexico. DENV, DF, DHF, RdRp
60  2007 A novel tetraspanin C189 upregulated in C6/36 mosquito cells following dengue 2 virus infection. nt
61  2007 An adenovirus prime/plasmid boost strategy for induction of equipotent immune responses to two dengue virus serotypes. Ad, rAd
62  2007 Construction and biological properties of yellow fever 17D/dengue type 1 recombinant virus. YF
63  2007 ELISA as an alternative tool for epidemiological surveillance for dengue in mosquitoes: a report from Thailand. DF, DHF, DSS, ELISA
64  2007 Induction of bivalent immune responses by expression of dengue virus type 1 and type 2 antigens from a single complex adenoviral vector. ---
65  2007 Single antigen detects both immunoglobulin M (IgM) and IgG antibodies elicited by all four dengue virus serotypes. EDIII, IgM
66  2007 Solution structure of the envelope protein domain III of dengue-4 virus. ---
67  2006 Evaluation of immunity and protective efficacy of a dengue-3 pre-membrane and envelope DNA vaccine in Aotus nancymae monkeys. ---
68  2006 Temporal distribution of dengue virus serotypes in Colombian endemic area and dengue incidence. Re-introduction of dengue-3 associated to mild febrile illness and primary infection. DHF
69  2005 Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes. ---
70  2005 Epidemiology of dengue and dengue hemorrhagic fever in a cohort of adults living in Bandung, West Java, Indonesia. DF, DHF, DSS
71  2005 Inhibition of dengue virus serotypes 1 to 4 in vero cell cultures with morpholino oligomers. DEN-2 virus
72  2005 Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys. TV
73  2005 Review on flavivirus vaccine development. Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26-27 April 2004, Bangkok, Thailand. JE, WHO
74  2005 Serotype-specific detection of dengue viruses in a fourplex real-time reverse transcriptase PCR assay. ---
75  2004 Analysis of the replication kinetics of the ChimeriVax-DEN 1, 2, 3, 4 tetravalent virus mixture in Aedes aegypti by real-time reverse transcriptase-polymerase chain reaction. i.t, prM, WT, YF
76  2004 Comparison of dengue-1 virus envelope glycoprotein gene sequences from French Polynesia. ---
77  2004 Complete genome sequencing of dengue virus type 1 isolated in Buenos Aires, Argentina. ---
78  2004 Dengue-specific CD8+ T cells have both protective and pathogenic roles in dengue virus infection. DEN-2, HepG2-grafted SCID, i.p, NMT, p.i
79  2004 Emergence and continued circulation of dengue-2 (genotype IV) virus strains in northern India. DF, DHF
80  2004 Introduction of the American/Asian genotype of dengue 2 virus into the Yucatan State of Mexico. ---
81  2004 Mosquito and mammalian cells grown on microcarriers for four-serotype dengue virus production: variations in virus titer, plaque morphology, and replication rate. MOI
82  2004 Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates. cGMP, prM, WT, YF
83  2004 Seroprevalence of IgG specific for dengue virus among adults and children in Santo Domingo, Dominican Republic. ---
84  2003 Biologic properties of dengue viruses following serial passage in primary dog kidney cells: studies at the University of Hawaii. PDK
85  2003 Comparative population dynamics of mosquito-borne flaviviruses. JE, ML
86  2003 Dengue virus M protein contains a proapoptotic sequence referred to as ApoptoM. ---
87  2003 Distribution of three arbovirus antibodies among monkeys (Macaca fascicularis) in the Philippines. CHIK, JE
88  2003 Evaluation of protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine against dengue 2 virus in mice. IL-12, NS1, RIP
89  2003 Expression of dengue ApoptoM sequence results in disruption of mitochondrial potential and caspase activation. ---
90  2003 Formalin-inactivated whole virus and recombinant subunit flavivirus vaccines. JE, PIV, TBE, WN, YF
91  2003 Increased apoptosis and expression of tumor necrosis factor-alpha caused by infection of cultured human monocytes with dengue virus. TNF-alpha
92  2003 Mechanisms of dengue virus-induced cell death. ---
93  2003 Molecular epidemiological study of dengue virus type 1 in Taiwan. nt
94  2003 Temperature sensitive mutations in the genes encoding the NS1, NS2A, NS3, and NS5 nonstructural proteins of dengue virus type 4 restrict replication in the brains of mice. ---
95  2003 The extent of homologous recombination in members of the genus Flavivirus. YF
96  2003 The pathogenesis of spinal cord involvement in dengue virus infection. RER
97  2002 Genetic variation within the premembrane coding region of dengue viruses from the Yucatan peninsula of Mexico. prM, SSCP
98  2001 Detection of dengue viral RNA in Aedes aegypti (Diptera: Culicidae) exposed to sticky lures using reverse-transcriptase polymerase chain reaction. RT-PCR
99  2001 Development of new vaccines against dengue fever and Japanese encephalitis. JE
100  2001 Epidemiological and ecological characteristics of past dengue virus infection in Santa Clara, Peru. ELISA